In sum, our data indicate that reducing the levels of sphingolipid synthesis with Myriocin, or antisense strategy against enzymes involved in sphingolipid synthesis, or reducing the levels of Pdk1or Mef2, are options that should be explored in FRDA models. This evidence concerns the gene MEF2A and Friedreich ataxia.